Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura

Posted on November 23rd, 2015 by

In a wide ranging interview, we find out what Reaxys PhD Prize Winner Dr. Hiroyuki Miyamura has been up to: Continue reading “David Evans Presents: Catching up with Reaxys PhD Prize winner Dr. Hiroyuki Miyamura” »

Eluding a Post-Antibiotic Era: The Challenge of Designing Novel Antibiotics

Posted on November 13th, 2015 by

As cases of drug-resistant pathogens multiply, the WHO warns of a “post-antibiotic era.” Designing novel antibiotics, however, remains a scientific challenge because achieving therapeutic efficacy requires painstaking testing of compound properties that often conflict. Continue reading “Eluding a Post-Antibiotic Era: The Challenge of Designing Novel Antibiotics” »

Using Reaxys for Lead Optimization: A Case Study

Posted on November 13th, 2015 by

Epigen Biosciences is a start-up pharmaceutical company that collaborates with academic groups to discover innovative drugs for a range of medical conditions, including renal diseases, cancer and CNS disorders. Co-founder Dr. Fabio Tucci met with Elsevier to discuss how Epigen researchers use Reaxys to support their application of advanced hit-to-lead and lead optimization methods. Continue reading “Using Reaxys for Lead Optimization: A Case Study” »

  1. 1
  2. 60
  3. 61
  4. 62